TauRx Therapeutics initiates two global Phase III clinical trials in mild to moderate Alzheimer’s…
The studies may provide the first definitive data on a Tau-based approach to disease-modifying and preventative treatment of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis to construct biotechnology facility in Singapore with an investment of over $500 million
Construction of new production facility to start in early 2013 and expected to be fully operational by the end of 2016
The patent pileup
Rise in applications for pharmaceutical patents is a good omen for the Indian pharma industry. However, lack of patent experts to…
Maharashtra to stop issuing license to branded drugs from October 20, 2012
IDMA-GSB invites associations to discuss the issue further
Polyclone Bioservices signs MoU with JSS University, Mysore
To expedite research and development of new methods and technologies
AstraZeneca launches patented life-saving heart drug
Brilinta is indicated to reduce heart attack and cardiovascular death in patients with Acute Coronary Syndromes (ACS)
Lupin receives FDA approval for generic Avapro and oral contraceptive Kurvelo tabs
Kurvelo tablets are the AB-rated generic equivalent of Teva’s Nordette tablets
PHARMA Pro&Pack Expo 2013 to co-locate PHARMEXCILS international exhibition IPHEX2013
DIA to partner PHARMA Pro&Pack Expo 2013
CTSE 2012 conference to showcase potential of clinical trial scenario in Southeast Asia
Conference to be held in Mumbai on November 23, 2012
Experts discuss future potential of bio pharma in India
Over 100 delegates participate in the conference